Quoin Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNRX and other ETFs, options, and stocks.

About QNRX

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. 

CEO
Michael Myers
CEOMichael Myers
Employees
5
Employees5
Headquarters
Ashburn, Virginia
HeadquartersAshburn, Virginia
Founded
1986
Founded1986
Employees
5
Employees5

QNRX Key Statistics

Market cap
5.65M
Market cap5.65M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
29.46K
Average volume29.46K
High today
$10.30
High today$10.30
Low today
$9.41
Low today$9.41
Open price
$9.59
Open price$9.59
Volume
30.94K
Volume30.94K
52 Week high
$41.80
52 Week high$41.80
52 Week low
$5.01
52 Week low$5.01

QNRX News

TipRanks 3d
Quoin seeks Saudi breakthrough status for Netherton therapy

Claim 50% Off TipRanks Premium The latest update is out from Quoin Pharmaceuticals ( (QNRX) ). On January 20, 2026, Quoin Pharmaceuticals announced that it ha...

TipRanks 4d
Quoin files Breakthrough Medicine Designation with SFDA for QRX003

Quoin Pharmaceuticals (QNRX) announced that it has filed an application for Breakthrough Medicine Designation with the Saudi Food and Drug Authority, SFDA, for...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.